Aytu BioScience (AY20) Ratios

0 Followers

Aytu BioScience Ratios

DE:AY20's free cash flow for Q4 2026 was $0.73. For the 2026 fiscal year, DE:AY20's free cash flow was decreased by $ and operating cash flow was $0.02. See a summary of the company’s cash flow.

Ratios	TTM	Jun 26	Jun 25	Jun 24	Jun 23
Liquidity Ratios
Current Ratio	1.13	1.13	1.26	0.99	1.06
Quick Ratio	1.00	1.00	1.07	0.80	0.88
Cash Ratio	0.48	0.48	0.49	0.32	0.33
Solvency Ratio	-0.15	-0.15	-0.08	-0.10	-0.08
Operating Cash Flow Ratio	0.06	0.06	-0.03	-0.02	-0.07
Short-Term Operating Cash Flow Coverage	0.40	0.40	-0.18	-0.28	-0.59
Net Current Asset Value	$ -7.97M	$ -7.97M	$ -26.03M	$ -29.25M	$ -25.65M
Leverage Ratios
Debt-to-Assets Ratio	0.17	0.17	0.18	0.14	0.22
Debt-to-Equity Ratio	0.51	0.51	1.21	0.59	0.77
Debt-to-Capital Ratio	0.34	0.34	0.55	0.37	0.44
Long-Term Debt-to-Capital Ratio	0.21	0.21	0.36	0.28	0.35
Financial Leverage Ratio	2.98	2.98	6.55	4.29	3.50
Debt Service Coverage Ratio	-0.91	-0.70	-0.35	-0.08	-0.24
Interest Coverage Ratio	-7.36	4.39	-2.11	-0.33	-3.44
Debt to Market Cap	0.74	0.65	1.59	1.00	5.54
Interest Debt Per Share	1.56	1.32	4.24	3.83	10.60
Net Debt to EBITDA	0.97	1.87	1.72	-2.55	-2.27
Profitability Margins
Gross Profit Margin	63.95%	63.95%	69.04%	75.26%	62.04%
EBIT Margin	-21.43%	-21.43%	-15.13%	-8.16%	-11.26%
EBITDA Margin	-14.74%	-7.62%	-7.03%	2.16%	-3.05%
Operating Profit Margin	-14.44%	-14.44%	-11.79%	-2.44%	-15.89%
Pretax Profit Margin	-24.72%	-24.72%	-20.71%	-15.92%	-15.88%
Net Profit Margin	-24.76%	-24.76%	-20.43%	-24.31%	-15.88%
Continuous Operations Profit Margin	-24.76%	-24.76%	-21.36%	-19.21%	-15.88%
Net Income Per EBT	100.15%	100.15%	98.67%	152.67%	100.00%
EBT Per EBIT	171.15%	171.15%	175.61%	652.29%	99.92%
Return on Assets (ROA)	-13.57%	-13.57%	-10.92%	-13.33%	-12.37%
Return on Equity (ROE)	-52.89%	-40.40%	-71.51%	-57.17%	-43.32%
Return on Capital Employed (ROCE)	-16.52%	-16.52%	-12.81%	-2.81%	-24.79%
Return on Invested Capital (ROIC)	-14.21%	-14.19%	-10.85%	-2.58%	-22.00%
Return on Tangible Assets	-22.41%	-22.41%	-16.54%	-23.86%	-21.62%
Earnings Yield	-53.31%	-53.81%	-99.07%	-100.39%	-319.08%
Efficiency Ratios
Receivables Turnover	2.53	2.53	2.13	2.77	3.71
Payables Turnover	1.84	1.84	1.94	1.56	3.02
Inventory Turnover	3.03	3.03	1.80	1.33	3.40
Fixed Asset Turnover	46.35	46.35	41.67	42.83	27.76
Asset Turnover	0.55	0.55	0.53	0.55	0.78
Working Capital Turnover Ratio	7.96	4.96	8.41	37.46	-308.62
Cash Conversion Cycle	66.61	66.61	186.10	173.08	85.07
Days of Sales Outstanding	144.42	144.42	171.31	131.74	98.34
Days of Inventory Outstanding	120.66	120.66	203.08	274.75	107.40
Days of Payables Outstanding	198.47	198.47	188.28	233.41	120.67
Operating Cycle	265.08	265.08	374.38	406.49	205.74
Cash Flow Ratios
Operating Cash Flow Per Share	0.27	0.27	-0.31	-0.25	-1.54
Free Cash Flow Per Share	0.26	0.26	-0.82	-0.31	-1.54
CapEx Per Share	<0.01	<0.01	0.51	0.06	0.00
Free Cash Flow to Operating Cash Flow	0.99	0.99	2.67	1.24	1.00
Dividend Paid and CapEx Coverage Ratio	113.14	113.14	-0.60	-4.22	0.00
Capital Expenditure Coverage Ratio	113.14	113.14	-0.60	-4.22	0.00
Operating Cash Flow Coverage Ratio	0.18	0.18	-0.08	-0.08	-0.17
Operating Cash Flow to Sales Ratio	0.06	0.06	-0.03	-0.02	-0.05
Free Cash Flow Yield	13.96%	12.28%	-37.73%	-10.88%	-95.98%
Valuation Ratios
Price-to-Earnings (P/E) Ratio	-1.87	-1.85	-1.01	-1.00	-0.31
Price-to-Sales (P/S) Ratio	0.40	0.46	0.21	0.24	0.05
Price-to-Book (P/B) Ratio	0.76	0.75	0.72	0.57	0.14
Price-to-Free Cash Flow (P/FCF) Ratio	7.16	8.14	-2.65	-9.19	-1.04
Price-to-Operating Cash Flow Ratio	8.15	8.07	-7.07	-11.37	-1.04
Price-to-Earnings Growth (PEG) Ratio	0.04	0.04	0.04	0.02	<0.01
Price-to-Fair Value	0.76	0.75	0.72	0.57	0.14
Enterprise Value Multiple	-1.78	-4.17	-1.22	8.67	-3.91
Enterprise Value	15.09M	18.28M	5.67M	12.20M	12.78M
EV to EBITDA	-1.78	-4.17	-1.22	8.67	-3.91
EV to Sales	0.26	0.32	0.09	0.19	0.12
EV to Free Cash Flow	4.64	5.62	-1.10	-7.10	-2.49
EV to Operating Cash Flow	4.60	5.57	-2.93	-8.79	-2.49
Tangible Book Value Per Share	-0.50	-0.50	-3.70	-4.47	-5.87
Shareholders’ Equity Per Share	2.86	2.86	3.02	5.00	11.78
Tax and Other Ratios
Effective Tax Rate	<0.01	<0.01	-0.03	-0.21	0.00
Revenue Per Share	4.67	4.67	10.57	11.77	32.16
Net Income Per Share	-1.16	-1.16	-2.16	-2.86	-5.11
Tax Burden	1.00	1.00	0.99	1.53	1.00
Interest Burden	1.15	1.15	1.37	1.95	1.41
Research & Development to Revenue	0.00	0.00	0.02	0.04	0.04
SG&A to Revenue	0.74	0.74	0.58	0.31	0.27
Stock-Based Compensation to Revenue	0.01	0.01	<0.01	0.04	0.06
Income Quality	-0.23	-0.23	0.14	0.09	0.30

Currency in USD